SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-15-000843
Filing Date
2015-11-19
Accepted
2015-11-19 15:57:32
Documents
2
Group Members
ORBIMED CAPITAL GP V LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss464351_sc13da.htm SC 13D/A 160198
2 JOINT FILING AGREEMENT ss464351_ex9901.htm EX-99.1 21403
  Complete submission text file 0000947871-15-000843.txt   183140
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Subject) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88267 | Film No.: 151243651
SIC: 2834 Pharmaceutical Preparations